http://www.tapanray.in A Tapan Ray Website Sun, 22 Mar 2026 10:59:18 +0000 en-US hourly 1 http://wordpress.org/?v=3.4.2 http://www.tapanray.in/drug-data-exclusivity-in-india-innovation-catalyst-or-affordability-risk-for-indian-pharma/?utm_source=rss&utm_medium=rss&utm_campaign=drug-data-exclusivity-in-india-innovation-catalyst-or-affordability-risk-for-indian-pharma http://www.tapanray.in/drug-data-exclusivity-in-india-innovation-catalyst-or-affordability-risk-for-indian-pharma/#comments Sat, 06 Dec 2025 14:33:27 +0000 Tapan Ray http://www.tapanray.in/?p=11008 Continue reading →]]> http://www.tapanray.in/drug-data-exclusivity-in-india-innovation-catalyst-or-affordability-risk-for-indian-pharma/feed/ 0 http://www.tapanray.in/meeting-indias-unmet-biologic-drug-needs-some-global-synergy-evident-but-patients-need-more/?utm_source=rss&utm_medium=rss&utm_campaign=meeting-indias-unmet-biologic-drug-needs-some-global-synergy-evident-but-patients-need-more http://www.tapanray.in/meeting-indias-unmet-biologic-drug-needs-some-global-synergy-evident-but-patients-need-more/#comments Mon, 17 Jul 2023 00:00:32 +0000 Tapan Ray http://www.tapanray.in/?p=10799 Continue reading →]]> http://www.tapanray.in/meeting-indias-unmet-biologic-drug-needs-some-global-synergy-evident-but-patients-need-more/feed/ 0 http://www.tapanray.in/to-allay-customers-new-apprehensions-pharma-needs-a-new-conversation/?utm_source=rss&utm_medium=rss&utm_campaign=to-allay-customers-new-apprehensions-pharma-needs-a-new-conversation http://www.tapanray.in/to-allay-customers-new-apprehensions-pharma-needs-a-new-conversation/#comments Mon, 17 May 2021 00:00:10 +0000 Tapan Ray http://www.tapanray.in/?p=10505 Continue reading →]]> http://www.tapanray.in/to-allay-customers-new-apprehensions-pharma-needs-a-new-conversation/feed/ 0 http://www.tapanray.in/impact-of-covid-vaccines-possible-ip-waiver-in-india/?utm_source=rss&utm_medium=rss&utm_campaign=impact-of-covid-vaccines-possible-ip-waiver-in-india http://www.tapanray.in/impact-of-covid-vaccines-possible-ip-waiver-in-india/#comments Mon, 10 May 2021 00:00:39 +0000 Tapan Ray http://www.tapanray.in/?p=10495 Continue reading →]]> http://www.tapanray.in/impact-of-covid-vaccines-possible-ip-waiver-in-india/feed/ 0 http://www.tapanray.in/exploring-an-exit-to-indias-covid-management-maze/?utm_source=rss&utm_medium=rss&utm_campaign=exploring-an-exit-to-indias-covid-management-maze http://www.tapanray.in/exploring-an-exit-to-indias-covid-management-maze/#comments Mon, 03 May 2021 00:00:11 +0000 Tapan Ray http://www.tapanray.in/?p=10487 Continue reading →]]> http://www.tapanray.in/exploring-an-exit-to-indias-covid-management-maze/feed/ 0 http://www.tapanray.in/come-covid-19-drug-and-vaccine-pharma-will-get-back-to-the-traditional-mode/?utm_source=rss&utm_medium=rss&utm_campaign=come-covid-19-drug-and-vaccine-pharma-will-get-back-to-the-traditional-mode http://www.tapanray.in/come-covid-19-drug-and-vaccine-pharma-will-get-back-to-the-traditional-mode/#comments Mon, 18 May 2020 00:00:53 +0000 Tapan Ray http://www.tapanray.in/?p=10084 Continue reading →]]> http://www.tapanray.in/come-covid-19-drug-and-vaccine-pharma-will-get-back-to-the-traditional-mode/feed/ 0 http://www.tapanray.in/pharmas-oncology-focus-some-key-drivers-with-pros-and-cons-for-patients/?utm_source=rss&utm_medium=rss&utm_campaign=pharmas-oncology-focus-some-key-drivers-with-pros-and-cons-for-patients http://www.tapanray.in/pharmas-oncology-focus-some-key-drivers-with-pros-and-cons-for-patients/#comments Mon, 28 Jan 2019 00:00:03 +0000 Tapan Ray http://www.tapanray.in/?p=9391 Continue reading →]]> http://www.tapanray.in/pharmas-oncology-focus-some-key-drivers-with-pros-and-cons-for-patients/feed/ 0 http://www.tapanray.in/access-to-comprehensive-healthcare-merits-multipronged-approach/?utm_source=rss&utm_medium=rss&utm_campaign=access-to-comprehensive-healthcare-merits-multipronged-approach http://www.tapanray.in/access-to-comprehensive-healthcare-merits-multipronged-approach/#comments Mon, 10 Dec 2018 00:00:58 +0000 Tapan Ray http://www.tapanray.in/?p=9296 Continue reading →]]> http://www.tapanray.in/access-to-comprehensive-healthcare-merits-multipronged-approach/feed/ 0 http://www.tapanray.in/an-interesting-demand-no-price-control-for-otc-drugs/?utm_source=rss&utm_medium=rss&utm_campaign=an-interesting-demand-no-price-control-for-otc-drugs http://www.tapanray.in/an-interesting-demand-no-price-control-for-otc-drugs/#comments Mon, 19 Nov 2018 00:00:50 +0000 Tapan Ray http://www.tapanray.in/?p=9286 Continue reading →]]> http://www.tapanray.in/an-interesting-demand-no-price-control-for-otc-drugs/feed/ 0 http://www.tapanray.in/draft-pharma-policy-2017-and-branded-generics/?utm_source=rss&utm_medium=rss&utm_campaign=draft-pharma-policy-2017-and-branded-generics http://www.tapanray.in/draft-pharma-policy-2017-and-branded-generics/#comments Sun, 27 Aug 2017 23:55:24 +0000 Tapan Ray http://www.tapanray.in/?p=8385 Continue reading →]]> http://www.tapanray.in/draft-pharma-policy-2017-and-branded-generics/feed/ 0